Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1954 1
1976 1
2005 1
2006 3
2007 4
2008 3
2009 1
2010 2
2011 5
2012 5
2013 4
2014 5
2015 7
2016 2
2017 2
2018 6
2019 2
2020 7
2021 9
2022 5
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Acute hepatitis A in a pregnant woman at delivery.
Motte A, Blanc J, Minodier P, Colson P. Motte A, et al. Int J Infect Dis. 2009 Mar;13(2):e49-51. doi: 10.1016/j.ijid.2008.06.009. Epub 2008 Sep 6. Int J Infect Dis. 2009. PMID: 18774327 Free article.
Fatal Fulminant Hepatitis E in a Diabetic Patient on Metformin.
Peroni E, Mora P, Motte A, Gerolami R, Aherfi S, Colson P. Peroni E, et al. Among authors: motte a. Diagnostics (Basel). 2022 Sep 30;12(10):2385. doi: 10.3390/diagnostics12102385. Diagnostics (Basel). 2022. PMID: 36292073 Free PMC article.
Developing Sets of Survey Questions to Measure Children's Sleep Health [Internet].
Forrest CB, Meltzer LJ, Marcus CL, de la Motte A, Kratchman A, Buysse DJ, Pilkonis PA, Becker BD, Bevans KB. Forrest CB, et al. Among authors: de la motte a. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2018 Sep. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2018 Sep. PMID: 38033153 Free Books & Documents. Review.
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G; ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43. Lemaitre F, et al. Br J Clin Pharmacol. 2024 Jan;90(1):264-273. doi: 10.1111/bcp.15890. Epub 2023 Sep 18. Br J Clin Pharmacol. 2024. PMID: 37602480 Free article.
Existing reporting guidelines for clinical trials are not completely relevant for implantable medical devices: a systematic review.
Motte AF, Diallo S, van den Brink H, Châteauvieux C, Serrano C, Naud C, Steelandt J, Alsac JM, Aubry P, Cour F, Pellerin O, Pineau J, Prognon P, Borget I, Bonan B, Martelli N. Motte AF, et al. J Clin Epidemiol. 2017 Nov;91:111-120. doi: 10.1016/j.jclinepi.2017.07.005. Epub 2017 Jul 18. J Clin Epidemiol. 2017. PMID: 28728922 Review.
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting.
Deschanvres C, Reynes J, Lamaury I, Rey D, Palich R, Bani-Sadr F, Robineau O, Duvivier C, Hocqueloux L, Cuzin L, Joly V, Raffi F, Cabie A, Allavena C; Dat’AIDS Study Group. Deschanvres C, et al. J Antimicrob Chemother. 2021 Dec 24;77(1):196-204. doi: 10.1093/jac/dkab367. J Antimicrob Chemother. 2021. PMID: 34651192
70 results